Efficacy of Single‐Dose Intravenous Ferric Derisomaltose for Iron Deficiency Anemia in Pregnancy
American Journal of Hematology · 2026
DOI: 10.1002/ajh.70190 ↗Kurz gefasst
Klinische Studie in der Zeitschrift American Journal of Hematology, 2026. Verfasst von Ashley E Benson und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, Oregon, USA. Hauptthemen laut MEDLINE: Anemia, Iron-Deficiency, Ferric Compounds, Pregnancy Complications, Hematologic, Maltose. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Center for Advancing Translational Sciences (NCATS), Pharmacosmos A/S, Holbaek, Denmark, National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH).
Abstract (Originalsprache)
Iron deficiency anemia (IDA) is prevalent in pregnancy, yet oral iron therapies are associated with poor adherence and many intravenous (IV) iron formulations require multiple doses for treatment. Ferric derisomaltose (FDI) is a newer IV iron formulation that is safe and efficacious in non‐pregnant individuals, yet pregnancy data is lacking. We evaluated the safety, efficacy, and maternal and neonatal outcomes associated with a single 1000 mg IV dose of FDI in pregnant individuals with IDA. We conducted a prospective, single‐arm interventional trial of FDI administered in the second or third trimester of pregnancy from January 2024 to July 2025. The primary outcome was efficacy (hemoglobin increase of ≥ 1 g/dL). Secondary outcomes included safety, other hematologic parameters, patient‐reported quality of life, and maternal and neonatal outcomes. Among 78 participants enrolled, 75 received FDI. From baseline to delivery, mean hemoglobin increased by 1.3 g/dL, with significant improvements ( p < 0.001) in ferritin and transferrin saturation through 6 weeks postpartum. Patient‐reported fatigue scores improved ( p < 0.001), as did Edinburgh Postnatal Depression Scale scores ( p = 0.003). The mean FDI infusion time was 24 min. Cord blood ferritin and hemoglobin values suggested enhanced neonatal iron status. No major infusion reactions or hospitalizations occurred. Minor infusion‐related symptoms were uncommon and self‐limited: chest tightness (6.7%), flushing (5.3%), mild shortness of breath (4%), urticaria (2.7%), rash (1.3%). Two patients (2.6%) did not complete the infusion due to reaction. These findings support single‐dose IV FDI as a safe and effective option for late‐pregnancy IDA, meriting further evaluation in larger controlled trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, Oregon, USA.
- Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.
- Department of Psychiatry, Oregon Health & Science University, Portland, Oregon, USA.
- Department of Obstetrics and Gynecology, Warren Alpert Medical School at Brown University, Providence, Rhode Island, USA.
ORCID-Profile: Kylee L Martens, Monica Rincon, Jamie O Lo
Förderung
- National Center for Advancing Translational Sciences (NCATS)
- Pharmacosmos A/S, Holbaek, Denmark
- National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH)
- NHLBI NIH HHS
- NIH HHS
- NIDA NIH HHS
- National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH)
- NCATS NIH HHS
Zitieren
APA
Benson, A. E., Martens, K. L., Rincon, M., Ward, L., Kelley, T. P., Sullivan, E. L., Lewkowitz, A. K., Tuuli, M. G., Graham, J. A., Shatzel, J. J., & Lo, J. O. (2026). Efficacy of Single‐Dose Intravenous Ferric Derisomaltose for Iron Deficiency Anemia in Pregnancy. American Journal of Hematology. https://doi.org/10.1002/ajh.70190
Vancouver
Benson AE, Martens KL, Rincon M, Ward L, Kelley TP, Sullivan EL, et al. Efficacy of Single‐Dose Intravenous Ferric Derisomaltose for Iron Deficiency Anemia in Pregnancy. American Journal of Hematology. 2026. doi:10.1002/ajh.70190
BibTeX
@article{Benson2026,
author = {Benson, Ashley E and Martens, Kylee L and Rincon, Monica and Ward, Lucy and Kelley, Thalia P and Sullivan, Elinor L and Lewkowitz, Adam K and Tuuli, Methodius G and Graham, Jason A and Shatzel, Joseph J and Lo, Jamie O},
title = {Efficacy of Single‐Dose Intravenous Ferric Derisomaltose for Iron Deficiency Anemia in Pregnancy},
journal = {American Journal of Hematology},
year = {2026},
doi = {10.1002/ajh.70190}
}
EUVIMED